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Fm* The prevailing neurochemical theory about biological 
correlates of suicidal behavior focuses on the serotonergic sys- 
tem. In this study, we assessed the cortisol, ACTH. GH. prolactin 
and temperature responses to flesinoxan, a5-HT1A agonist, in 
30 DSM-Ill-R major depressed inpatients subgrouped into suicide 
attempters (n = 15) and nonattempters (n = 15). Thepatientswere 
assessed after a drug-free period of at  least 3 weeks. Asubsample 
of 16 patients completed the Buss-Durkee Hostility Inventory as 
a measure of impulsive aggressive behavior. Mean delta cortisol 
responses to flesinoxan were significantly lower in the group of 
depressed patients with a history of suicide attempts than in the 
group without history of suicidal behavior: for the delta cortisol 
values 14.5k16.3 pg/I vs 101 *94pg/1 (F=8.9. df=5.25, p=  
0.006). There was also a very significant difference between 
suicide attempters and nonattempters forthe temperature(de1ta 
To) responses to flesinoxan: 0.20 f 0.24 "C vs 0.60 f 0.24 OC (F= 
18.1. df-5.25, p=0.0003). Hormonal and temperature responses 
to flesinoxan were not correlated with BDHl irritability or assault 
subscale scores. The results of the present study support the im- 
plication of the serotonergic system, particularly 5-HT1A recep- 
tors, in the control of self-directed aggressive behavior. Moreover, 
in  depressed patients, serotonergic abnormalities do not appear 
to be related to aggressive behavlor. 
In most countries. suicide ranks among the top 10 causes of 
death for people of all ages and among the 2 or 3 principal 
causes of death for individuals aged from 15 to 34 years. In 
fact, suicide appears to be a very significant public health prob- 
lem. Therefore, prediction and prevention of suicide are 
priorities in psychiatric research. For many years, studies about 
suicidal behavior have largely focused on the role of psycho- 
social factors in the development of autoaggressive behaviors. 
Risk factors include male gender for suicide and female gender 
for suicide attempt, increasing age, loneliness, physical illness. 
history of recent loss, previous suicidal behavior, and hope- 
lessness. However, the most important risk factor seems to be 
the presence of a psychiatric illness. indeed. 90 % of suicides 
are related to a psychiatric disorder. particularly depression. 
but also alcoholism, schizophrenia, and anxiety disorders 
(Weissman, et al., 1989; Henriksson, et al.. 1993: Rudd, et al.. 
1993). However, as suicide is a relatively rare event. the appli- 
cation of these factors in a strategy of prediction and preven- 
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tion of suicidal behavjor is rather disappointing. In the last de- 
cade, several studjes have suggested that suicidal behavior 
could be in relationship with biological abnormalities, and par- 
ticularly with serotonergic dysfunctions (Asberg, et al., 1987). 
In this context, the development of a "biological marker" of 
suicidal behavior could be useful in the clinical assessment of 
the suicide risk. 
As a first step, we conducted a study to validate a 'flesinoxan 
test" as a serotonergic probe in normal volunteers by showing 
a reliable and dose-dependent release of various hormones. 
Moreover, in order to confirm the selective serotonergic mech- 
anisms implicated in the hormonal response to flesinoxan, a 
strategy using various serotonergic antagonists was used. Until 
now, no reliable serotonergic hormonal probe for i.v. use has 
been demonstrated. despite various attempts to stimulate pro- 
lactin, cortisol, or GH with several postulated serotonergic 
agonists, such as 5-HTP. fenfluramine. mCPP. or ipsapirone. 
These challenges lack serotonergic selectivity and/or are not 
available for i.v. use: oral administration is compromised by 
low bioavailability and varying pharmacokinetic parameters. 
Flesinoxan is a highly potent and selective 5-HTlA agonist In 
a double-blind placebo-controlled study, single doses of 0.5 
mg and 1 mg were injected over 10 min into 12 healthy male 
volunteers at I-week intervals: temperature and hormonal re- 
sponses (ACTH, cortisol, PRL. GH, total neurophysins, and va- 
sopressin-neurophysins) were measured at times - 30. 0, 15, 
30, 60. 90, and 120 min. Flesinoxan induced a significant and 
dose-dependent increase in A C M ,  cortisol, PRL. CH, and total 
neurophysins and a decrease in body temperature. The toler- 
ance of flesinoxan was excellent and associated with a pleasant 
feeling of relaxation and a slight drowsiness without signifi- 
cant GI side-effects. Subsequently, these hormonal and tem- 
perature responses to flesinoxan were studied with or without 
pretreatment with ritanserin, a selective 5HT2 antagonist (10 
mg p.0.). or with pindolol, a beta-antagonist and 5HTlA anta- 
gonist (30 mg p.0.). The volunteers received at  2-week inter- 
vals, in double-blind and crossover conditions, either: 1. flesi- 
noxan 1 mg preceded 90 min earlier by placebo; 2. flesinoxan 
1 mg preceded by antagonist; 3. placebo i.v. preceded by an- 
tagonist; 4. placebo i.v. preceded by placebo. Pindolol signifi- 
cantly antagonized the prolactin (p < 0.05). AOH (p = 0.01). GH 
(p < 0.01 ), and temperature (p < 0.05) responses to flesinoxan. 
Ritanserin significantly antagonized the prolactin (p = 0.01) 
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show the role of the 5-HT1A mechanisms in the prolactin, 
ACTH. GH, and temperature response to flesinoxan. and the 
role of the 5-HT2 mechanisms in rhe prolactin and ACTH re- 
sponses to flesinoxan. Flesinoxan thus appears to fulfi I1 all the 
criteria for an ideal serotonergic neuroendocrine probe. 
In a second step, the flesinoxan rest was applied in depressed 
patients with and without suicidal behavior. Suicidal behavior 
has been associated with a reduction of serotonergic activity. 
Indeed, several studies have demonstrated a relationship be- 
tween low concentrations of cerebrospinal fluid 5-hydroxyin- 
dolacetic acid (5-HIM) and a history of suicide attempts. How- 
ever, CSF measures of the metabolites of serotonin represent 
presynaptic indices of serotonergic activity. In contrast, neu- 
roendocrine strategy may provide an indirect index of central 
neurotransmission at  the postsynaptic receptor level and test 
the functional state of neurotransmission systems. Such a 
strategy has already been applied in depressed patients with 
a history of suicide attempts, using the 5-HT releaserlreup- 
take-inhibitor fenfluramine. Coccaro et al. (1989) reported a 
reduced prolactin response to fenfluramine in patients with 
major affective disorder and/or personality disorder with a 
past history of suicidal behavior. In 1984. Meltzer et al. showed 
increased cortisol responses to 5-HTP challenge in depressed 
suicide attempters. The contradiction between these results 
could be explained by the fact that the serotonergic precursors 
used in these neuroendocrine studies stimulate different types 
of receptors. In fact. these challenges are unable to provide in- 
formation about which types of 5-HT receptors are implicated 
in suicidal behavior. 
In this study, we assessed the cortisol, ACTH, GH, prolactin. 
and temperature responses to flesinoxan in 30DMS-111-R 
major depressed inpatients subgrouped into suicide attemp- 
ters (n  = 15) and nonattempters (n = 15) and compared to nor- 
mal controls (n = 12). The patients were assessed after a drug- 
free period of at least 3 weeks. A subsample of 16 patients 
completed the Buss-Durkee Hostility Inventory as a measure 
of impulsive aggressive behavior. There was no significant dif- 
ference between depressed parients and normal controls for 
hormonal and temperature responses to flesinoxan. However. 
mean delta cortisol responses to flesinoxan were significantly 
lower in the group of depressed patients with a history of 
suicide attempts than in the group without histow of suicidal 
behavior: 14.5 f 16.3 pg/l vs 101 +94 pg/l ( F  = 8.9. df = 5, 25. p = 
0.006). There was also a very significant difference between 
suicide attempters and nonattempters for the temperature re- 
sponses to flesinoxan: 0.20f 0.24 O C  vs 0.60f 0.24 OC (F= 18.1. 
df = 5, 25, p = 0.0003). No significant group differences were 
observed with regard to PRL, GH. or ACTH. Hormonal and tem- 
perature responses to flesinoxan were not correlated with 
BDHl irritability or assault subscale scores. 
Conclusion 
HIM assessment and it could be very useful in clinical prac- 
tice in order to predict suicide risk. 
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The results of this study confirm the major role of serotonin, 
and particularly 5-HTIA receptors, in the control of inward- 
directed aggressiveness in major depression and suggest that 
blunted cortisol and temperature responses to flesinoxan 
could be considered as "biological marl<en" of suicidal behav- 
ior. Moreover, the flesinoxan test. and particularly the tem- 
perature response to flesinoxan, is a less invasive method of 
assessing central serotonergic neurotransmission than CSF 5- 
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